Il y a eu 50 transactions d'initiés récentes enregistrées pour Tarsus Pharmaceuticals, Inc. (TARS), dont 9 achats et 38 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $8.71M.
Les initiés notables ayant une activité récente comprennent Neervannan Seshadri, Farrow Jeffrey S, Mottiwala Aziz. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — TARS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
Vente Informative |
2,989 |
$66.75 |
$199.52K |
82,791 |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
Vente Informative |
2,186 |
$67.00 |
$146.46K |
43,316 |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
Vente Informative |
4,440 |
$67.00 |
$297.48K |
61,480 |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
Vente Informative |
4,589 |
$67.00 |
$307.46K |
85,780 |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
Vente Informative |
11,964 |
$67.00 |
$801.59K |
33,421 |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Vente Informative |
4,174 |
$67.00 |
$279.66K |
35,028 |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
Vente Informative |
4,231 |
$67.00 |
$283.48K |
63,959 |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Vente Informative |
390 |
$67.00 |
$26.13K |
23,308 |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
Vente Informative |
2,133 |
$68.71 |
$146.56K |
45,502 |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
Vente Informative |
4,330 |
$68.71 |
$297.51K |
65,920 |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
Vente Informative |
3,610 |
$68.71 |
$248.04K |
90,369 |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
Vente Informative |
11,667 |
$68.71 |
$801.64K |
45,385 |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Vente Informative |
4,071 |
$68.71 |
$279.72K |
39,202 |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
Vente Informative |
4,125 |
$68.71 |
$283.43K |
68,190 |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Vente Informative |
379 |
$68.71 |
$26.04K |
23,698 |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
Vente Informative |
2,111 |
$69.42 |
$146.55K |
47,635 |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
Vente Informative |
4,286 |
$69.42 |
$297.53K |
70,250 |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
Vente Informative |
3,125 |
$69.42 |
$216.94K |
93,979 |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
Vente Informative |
10,972 |
$69.42 |
$761.68K |
57,052 |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Vente Informative |
4,029 |
$69.42 |
$279.69K |
43,273 |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
Vente Informative |
4,084 |
$69.42 |
$283.51K |
72,315 |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Vente Informative |
375 |
$69.42 |
$26.03K |
24,077 |
| 2026-03-16 |
Link William J Phd |
Director |
Vente Informative |
493 |
$69.75 |
$34.39K |
116,332 |
| 2026-03-15 |
Farrow Jeffrey S |
See Remarks |
Exercice d'Options (Vente) |
5,022 |
- |
- |
15,067 |
| 2026-03-15 |
Mottiwala Aziz |
Chief Commercial Officer |
Exercice d'Options (Vente) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Neervannan Seshadri |
Chief Operating Officer |
Exercice d'Options (Vente) |
5,097 |
- |
- |
- |
| 2026-03-15 |
Azamian Bobak R. |
President/ceo and Board Chair |
Exercice d'Options (Vente) |
11,300 |
- |
- |
- |
| 2026-03-15 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Exercice d'Options (Vente) |
4,463 |
- |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
Exercice d'Options (Vente) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Exercice d'Options (Vente) |
2,511 |
- |
- |
7,534 |
| 2026-03-05 |
Farrow Jeffrey S |
See Remarks |
Attribution de RSU |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Mottiwala Aziz |
Chief Commercial Officer |
Attribution de RSU |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Neervannan Seshadri |
Chief Operating Officer |
Attribution de RSU |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Azamian Bobak R. |
President/ceo and Board Chair |
Attribution de RSU |
60,776 |
- |
- |
60,776 |
| 2026-03-05 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Attribution de RSU |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Wahl Bryan |
General Counsel |
Attribution de RSU |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Attribution de RSU |
17,161 |
- |
- |
17,161 |
| 2026-03-04 |
Neervannan Seshadri |
Chief Operating Officer |
Vente Informative |
8,366 |
$76.67 |
$641.42K |
70,817 |
| 2026-02-18 |
Pyott David E I |
Director |
Inconnu |
7,000 |
$12.97 |
$90.79K |
- |
| 2026-02-18 |
Pyott David E I |
Director |
Attribution de RSU |
3,729 |
- |
- |
3,729 |
| 2026-01-02 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Vente Informative |
893 |
$82.93 |
$74.06K |
23,393 |
| 2025-12-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
Vente Informative |
557 |
$83.54 |
$46.53K |
857,991 |
| 2025-12-16 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Vente Informative |
2,078 |
$79.50 |
$165.2K |
21,941 |
| 2025-12-16 |
Neervannan Seshadri |
Chief Operating Officer |
Don (Reçu) |
475 |
- |
- |
475 |
| 2025-12-16 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Vente Informative |
7,397 |
$80.10 |
$592.5K |
38,958 |
| 2025-12-15 |
Goodrich Katherine |
Director |
Exercice d'Options |
2,233 |
- |
- |
2,233 |
| 2025-12-15 |
Link William J Phd |
Director |
Vente Informative |
4,766 |
$81.50 |
$388.43K |
- |
| 2025-12-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Exercice d'Options (Vente) |
6,819 |
- |
- |
20,459 |
| 2025-12-04 |
Azamian Bobak R. |
President/ceo and Board Chair |
Don (Donné) |
51,885 |
- |
- |
1,750 |
| 2025-09-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
Vente Informative |
6,000 |
$55.37 |
$332.22K |
812,106 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
